News

Emirates News Agency on MSN17h
DoH explores establishing genome surgery centres with UCSF, IGI
Abu Dhabi (DoH) has announced a landmark partnership with the University of California, San Francisco (UCSF) and the ...
Emirates News Agency on MSN20h
DoH, UCSF, Innovative Genomics Institute explore establishing world’s first-of-their kind centres for Genome surgery
Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the ...
DoH, USCF and IGI Explore Establishing the World's first-of-their kind Centres for Genome Surgery
Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the ...
GlobalData on MSN16h
Vertex reports long-term results for Casgevy in sickle cell and thalassaemia
Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...
Managed Healthcare Executive22h
Rising SCAC Incidence and Evolving First-Line Standards
A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...
PharmiWeb4h
Gene Synthesis Market to Soar to USD 6.2 Billion by 2035
The global gene synthesis market is estimated to be valued at USD 1,089.3 million in 2025 and is projected to reach USD 6,203.6 million by 2035, registering a compound annual growth rate of 19% over ...
Managed Healthcare Executive21h
Research Review: POD1UM-303 and Impact in Metastatic SCAC Clinical Practice
A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...